Reset Map6 Results
Am Haag 6 Gräfelfing , Bayern, 82166 GermanyRevvity Gene Delivery, where SIRION Biotech’s expertise lives on, supports your cell and gene therapy development process, offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, Revvity Gene Delivery has you covered, supporting you through every phase of your cell and gene therapy development. The Revvity gene delivery advantage With clients in Cancer Research, Neurosciences, Regenerative Medicines, Gene Therapy, CAR-T Cell Development & Vaccine Development, we understand the technical challenges of viral vector engineering and manufacturing, no matter what your application. More than 15 years of viral vector development and production experience - Flexible production scales up to 50 liters - Extensive range of customizable QC options - CDMO network for smooth transfer of processes to GMP manufacturing - Comprehensive consultation and project management by viral vector experts Research and discovery: - Therapeutic payload identification (e.g. microRNA sequences) - Novel AAV capsid engineering (e.g.AAV Evolution) - Nanobody targeting Viral vector development: - Optimized Viral Vector Backbones - Therapeutic payload cassette optimization - Lentivirus surface modification technology Preclinical manufacture: - Upstream and downstream process development (non-GMP) - Up to 50L AAV manufacturing capacity - PoC and biodistribution studies of lead candidate batches with a CRO network Revvity offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types like CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST® is currently included in more than 20 Phase III and I/II clinical trials.
19 Am Klopferspitz Planegg, BY, 82152 GermanyRevvity Gene Delivery, where SIRION Biotech’s expertise lives on, supports your cell and gene therapy development process, offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, Revvity Gene Delivery has you covered, supporting you through every phase of your cell and gene therapy development. The Revvity gene delivery advantage With clients in Cancer Research, Neurosciences, Regenerative Medicines, Gene Therapy, CAR-T Cell Development & Vaccine Development, we understand the technical challenges of viral vector engineering and manufacturing, no matter what your application. More than 15 years of viral vector development and production experience - Flexible production scales up to 50 liters - Extensive range of customizable QC options - CDMO network for smooth transfer of processes to GMP manufacturing - Comprehensive consultation and project management by viral vector experts Research and discovery: - Therapeutic payload identification (e.g. microRNA sequences) - Novel AAV capsid engineering (e.g.AAV Evolution) - Nanobody targeting Viral vector development: - Optimized Viral Vector Backbones - Therapeutic payload cassette optimization - Lentivirus surface modification technology Preclinical manufacture: - Upstream and downstream process development (non-GMP) - Up to 50L AAV manufacturing capacity - PoC and biodistribution studies of lead candidate batches with a CRO network Revvity offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types like CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST® is currently included in more than 20 Phase III and I/II clinical trials.
Am Haag 6 Am Haag 6 Graefelfing, 82166 GermanyRevvity Gene Delivery, where SIRION Biotech’s expertise lives on, supports your cell and gene therapy development process, offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, Revvity Gene Delivery has you covered, supporting you through every phase of your cell and gene therapy development. The Revvity gene delivery advantage With clients in Cancer Research, Neurosciences, Regenerative Medicines, Gene Therapy, CAR-T Cell Development & Vaccine Development, we understand the technical challenges of viral vector engineering and manufacturing, no matter what your application. More than 15 years of viral vector development and production experience - Flexible production scales up to 50 liters - Extensive range of customizable QC options - CDMO network for smooth transfer of processes to GMP manufacturing - Comprehensive consultation and project management by viral vector experts Research and discovery: - Therapeutic payload identification (e.g. microRNA sequences) - Novel AAV capsid engineering (e.g.AAV Evolution) - Nanobody targeting Viral vector development: - Optimized Viral Vector Backbones - Therapeutic payload cassette optimization - Lentivirus surface modification technology Preclinical manufacture: - Upstream and downstream process development (non-GMP) - Up to 50L AAV manufacturing capacity - PoC and biodistribution studies of lead candidate batches with a CRO network Revvity offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types like CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST® is currently included in more than 20 Phase III and I/II clinical trials.
Am Haag 6 Graefelfing, 82166 GermanyRevvity Gene Delivery, where SIRION Biotech’s expertise lives on, supports your cell and gene therapy development process, offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, Revvity Gene Delivery has you covered, supporting you through every phase of your cell and gene therapy development. The Revvity gene delivery advantage With clients in Cancer Research, Neurosciences, Regenerative Medicines, Gene Therapy, CAR-T Cell Development & Vaccine Development, we understand the technical challenges of viral vector engineering and manufacturing, no matter what your application. More than 15 years of viral vector development and production experience - Flexible production scales up to 50 liters - Extensive range of customizable QC options - CDMO network for smooth transfer of processes to GMP manufacturing - Comprehensive consultation and project management by viral vector experts Research and discovery: - Therapeutic payload identification (e.g. microRNA sequences) - Novel AAV capsid engineering (e.g.AAV Evolution) - Nanobody targeting Viral vector development: - Optimized Viral Vector Backbones - Therapeutic payload cassette optimization - Lentivirus surface modification technology Preclinical manufacture: - Upstream and downstream process development (non-GMP) - Up to 50L AAV manufacturing capacity - PoC and biodistribution studies of lead candidate batches with a CRO network Revvity offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types like CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST® is currently included in more than 20 Phase III and I/II clinical trials.
125 Cambridgepark Drive Suite 301 Cambridge, MA, 02140 United StatesRevvity Gene Delivery, where SIRION Biotech’s expertise lives on, supports your cell and gene therapy development process, offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, Revvity Gene Delivery has you covered, supporting you through every phase of your cell and gene therapy development. The Revvity gene delivery advantage With clients in Cancer Research, Neurosciences, Regenerative Medicines, Gene Therapy, CAR-T Cell Development & Vaccine Development, we understand the technical challenges of viral vector engineering and manufacturing, no matter what your application. More than 15 years of viral vector development and production experience - Flexible production scales up to 50 liters - Extensive range of customizable QC options - CDMO network for smooth transfer of processes to GMP manufacturing - Comprehensive consultation and project management by viral vector experts Research and discovery: - Therapeutic payload identification (e.g. microRNA sequences) - Novel AAV capsid engineering (e.g.AAV Evolution) - Nanobody targeting Viral vector development: - Optimized Viral Vector Backbones - Therapeutic payload cassette optimization - Lentivirus surface modification technology Preclinical manufacture: - Upstream and downstream process development (non-GMP) - Up to 50L AAV manufacturing capacity - PoC and biodistribution studies of lead candidate batches with a CRO network Revvity offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types like CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST® is currently included in more than 20 Phase III and I/II clinical trials.
360 Merrimack Street Lawrence, MA, 01843 United StatesRevvity Gene Delivery, where SIRION Biotech’s expertise lives on, supports your cell and gene therapy development process, offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, Revvity Gene Delivery has you covered, supporting you through every phase of your cell and gene therapy development. The Revvity gene delivery advantage With clients in Cancer Research, Neurosciences, Regenerative Medicines, Gene Therapy, CAR-T Cell Development & Vaccine Development, we understand the technical challenges of viral vector engineering and manufacturing, no matter what your application. More than 15 years of viral vector development and production experience - Flexible production scales up to 50 liters - Extensive range of customizable QC options - CDMO network for smooth transfer of processes to GMP manufacturing - Comprehensive consultation and project management by viral vector experts Research and discovery: - Therapeutic payload identification (e.g. microRNA sequences) - Novel AAV capsid engineering (e.g.AAV Evolution) - Nanobody targeting Viral vector development: - Optimized Viral Vector Backbones - Therapeutic payload cassette optimization - Lentivirus surface modification technology Preclinical manufacture: - Upstream and downstream process development (non-GMP) - Up to 50L AAV manufacturing capacity - PoC and biodistribution studies of lead candidate batches with a CRO network Revvity offer LentiBOOST®, a highly effective lentiviral transduction enhancer for therapeutic cell types like CAR-T cells and CD34+ hematopoietic stem cells. LentiBOOST® is currently included in more than 20 Phase III and I/II clinical trials.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.